Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
16.63
0.54 (3.36%)
At close: Jun 16, 2025, 3:59 PM
16.40
-1.35%
After-hours: Jun 16, 2025, 04:20 PM EDT

Telix Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2018
Digital Product Sales Revenue 35.87M
Digital Product Sales Revenue Growth n/a
Digital Product Lease And Maintenance Revenue 4.88M
Digital Product Lease And Maintenance Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2024
Australia Revenue 1.22M
Australia Revenue Growth n/a
Belgium Revenue 546K
Belgium Revenue Growth n/a
Canada Revenue 2.54M
Canada Revenue Growth n/a
United States Revenue 762.31M
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 820.65K 1.68M 1.88M 1.56M 1.74M 4.28M 1.96M 1.76M -6.58M 1.93M 1.84M 1.88M 1.93M 2.43M 2.05M 2.4M 3.17M 2.33M 2.47M 2.3M
Selling, General, and Administrative Revenue Growth -51.06% -10.71% +20.42% -10.61% -59.22% +118.31% +11.18% -126.77% -441.99% +4.87% -2.28% -2.87% -20.55% +18.97% -14.77% -24.37% +36.01% -5.54% +7.33% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a